Society guideline links: Glomerular disease in adults

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Vasculitis" and "Society guideline links: Systemic lupus erythematosus" and "Society guideline links: Chronic kidney disease in adults" and "Society guideline links: Chronic kidney disease in children" and "Society guideline links: Acute kidney injury in adults" and "Society guideline links: Acute kidney injury in children" and "Society guideline links: Kidney transplantation" and "Society guideline links: Diabetes mellitus in adults".)

International

●Kidney Disease: Improving Global Outcomes (KDIGO): Clinical practice guideline for the management of glomerular diseases (2021)

●KDIGO: Management and treatment of glomerular diseases (part 1) – Conclusions from a KDIGO Controversies Conference (2019)

●KDIGO: Management and treatment of glomerular diseases (part 2) – Conclusions from a KDIGO Controversies Conference (2019)

Canada

●Choosing Wisely Canada: Don't prescribe angiotensin converting enzyme (ACE) inhibitors in combination with angiotensin II receptor blockers (ARBs) for the treatment of hypertension, diabetic nephropathy and heart failure (2017)

United States

●Choosing Wisely: Do not initiate a work up for hematuria or proteinuria before repeating an abnormal urine dipstick analysis (UA) (2018)

●National Kidney Foundation–Kidney Disease Outcomes Quality Initiative (NKF-KDOQI): US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis (published 2013)

●American College of Rheumatology (ACR): Guidelines for screening, treatment, and management of lupus nephritis (2012)

Europe

●European League Against Rheumatism (EULAR) and European Renal Association-European Dialysis and Transplant Association (ERA-EDTA): Joint recommendations for the management of lupus nephritis, 2019 update (published 2020)

●EULAR: Recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases, update (2019)

●EULAR: Recommendations for the management of large vessel vasculitis, 2018 update (published 2019)

●EULAR: Recommendations for the management of systemic lupus erythematosus, update (2019)

●EULAR: Recommendations for the use of imaging in large vessel vasculitis in clinical practice (2017)

●EULAR/ERA-EDTA: Recommendations for the management of ANCA-associated vasculitis (2016)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Clinical guideline on chronic kidney disease – Assessment and management (2021)

●British Committee for Standards in Haematology (BCSH): Guidelines for the diagnosis and investigation of AL amyloidosis (2014)

●BCSH: Guidelines for the management of AL amyloidosis (2014)

Australia-New Zealand

●Australian Creatinine Consensus Working Group: Position statement on chronic kidney disease and automatic reporting of estimated glomerular filtration rate – New developments and revised recommendations (2012)

●Australasian Proteinuria Consensus Working Group: Chronic kidney disease and measurement of albuminuria or proteinuria – A position statement (2012)

Japan

●[In English] Japanese Society of Nephrology (JSN) and Ministry of Health, Labour and Welfare (MHLW): Evidence-based clinical practice guidelines for IgA nephropathy, 2014 (published 2015)

●[In Japanese] JSN and MHLW: Evidence-based clinical practice guidelines for IgA nephropathy (2014)

●[In English] JSN and MHLW: Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis (2014)

●[In Japanese] JSN and MHLW: Evidence-based clinical practice guidelines for rapidly progressive nephritic syndrome (2014)

●[In English] JSN and MHLW: Evidence-based clinical practice guidelines for nephrotic syndrome (2014)

●[In Japanese] JSN and MHLW: Evidence-based clinical practice guidelines for nephrotic syndrome (2014)

●[In English] Asian Lupus Nephritis Network (ALNN): Overview of lupus nephritis management guidelines and perspective from Asia (2013)

●[In English] JSN, Japanese Urological Association (JUA), Japanese Society for Pediatric Nephrology (JSPN), Japanese Society of Laboratory Medicine (JSLM) and Japanese Association of Medical Technologists (JAMT): Japanese guidelines of the management of hematuria (2013)

●[In Japanese] JSN, JUA, JSPN, JSLM, and JAMT: Japanese guidelines of the management of hematuria (2013)

●[In English] Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI): Asian chronic kidney disease best practice recommendations – Positional statements for early detection of chronic kidney disease (2011)

●[In Japanese] MHLW: Amyloidosis clinical practice guidelines (2010)